2554. Safety and Immunogenicity of NasoVAX, a Novel Intranasal Influenza Vaccine

BACKGROUND: NasoVAX is a replication-deficient adenovirus-based vaccine designed to express influenza hemagglutinin in nasal epithelial cells when given as a nasal spray. In preclinical studies, NasoVAX was associated with divergent strain protection. Prior preclinical and clinical studies with the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Tasker, Sybil, Krishnan, Vyjayanthi, Bart, Stephan, Suyundikov, Anvar, Booth, Peta-Gay, Wight O’Rourke, Anna, Zhang, Jianfeng, Georges, Bertrand, Roberts, Scot
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6253025/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy209.162
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados